http://archive.fast-edgar.com/20240510/AP22N222Z222K2Z2222N22OZQ9ANE3I2A262
Filed on: May 10, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 9, 2024
United Bankshares, Inc.
(Exact name of registrant as specified in its charter)
West Virginia No. 002-86947 55-0641179
(State or other jurisdiction of
incorporation or... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 10, 2024
Fusion Pharmaceuticals Inc.
(Exact name of Registrant as Specified in Its Charter)
Canada 001-39344 (State... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K UNITED BANKSHARES INC/WV For: May 09
-
Form 10-Q Soho House & Co Inc. For: Mar 31
-
Form D Trially Mar 2024 a Serie
-
Form 8-K Sphere Entertainment For: May 10
-
Form 8-K Soho House & Co Inc. For: May 10
-
Form 8-K Neurogene Inc. For: May 10
-
Form SD Vontier Corp
-
Form 10-Q Akero Therapeutics, Inc. For: Mar 31
-
Form 10-Q Inspired Entertainment, For: Mar 31
-
Form 10-Q Wave Life Sciences Ltd. For: Mar 31
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: HEDRICK MARC H
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 8-K OVERSEAS SHIPHOLDING For: May 10
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Clowes Howard
-
Form DEFR14A SHF Holdings, Inc.
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Petersen Greg
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Hawkins Richard J
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Lenk Robert P
-
Form 4 Westlake Chemical Partne For: May 08 Filed by: Kenner Andrew
-
Form 10-Q American Strategic Inves For: Mar 31
-
Form 10-Q Deciphera Pharmaceutical For: Mar 31
-
Form 8-K United Homes Group, Inc. For: May 10
-
Form 8-K American Strategic Inves For: May 10
-
Form D/A Parsifal Offshore Ltd.
-
Form 13F-HR HOMESTEAD ADVISERS CORP For: Mar 31
-
Form 8-K Star Holdings For: May 10
-
Form 10-Q Protalix BioTherapeutics For: Mar 31
-
Form D/A Parsifal Fund, LP
-
Form 8-K Douglas Elliman Inc. For: May 09
-
Form 8-K Akero Therapeutics, Inc. For: May 10
-
Form 8-K SANUWAVE Health, Inc. For: May 10
-
Form SD BECTON DICKINSON & CO
-
Form D/A Parsifal Master Fund
-
Form 8-K Sylvamo Corp For: May 10
-
Form 8-K Inspired Entertainment, For: May 10
-
Form 8-K Workhorse Group Inc. For: May 10
-
Form 10-Q Star Holdings For: Mar 31
-
Form 13F-HR Banco Santander, S.A. For: Mar 31
-
Form 6-K Crescent Point Energy For: May 10
-
Form 10-Q Luminar Technologies, For: Mar 31
-
Form 10-Q Instil Bio, Inc. For: Mar 31
-
Form 8-K Aeluma, Inc. For: May 10
-
Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31
-
Form 8-K Mondee Holdings, Inc. For: May 10
-
Form D CR-0318 Fund II, a serie
-
Form 13F-NT Grupo Empresarial Santan For: Mar 31
-
Form D/A Dark Forest Global Equit
-
Form 13F-HR Intermede Investment For: Mar 31
-
Form 8-K Humacyte, Inc. For: May 10
-
Form 8-K i3 Verticals, Inc. For: May 10